PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.95%
Revenue growth under 50% of QCOM's 15.74%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.45%
Gross profit growth under 50% of QCOM's 13.26%. Michael Burry would be concerned about a severe competitive disadvantage.
-0.33%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.33%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
0.90%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
1.79%
Positive EPS growth while QCOM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1.82%
Positive diluted EPS growth while QCOM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.94%
Share reduction while QCOM is at 1.91%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.17%
Reduced diluted shares while QCOM is at 2.49%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.03%
Dividend reduction while QCOM stands at 0.35%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
22.29%
OCF growth under 50% of QCOM's 3583.33%. Michael Burry might suspect questionable revenue recognition or rising costs.
10.25%
FCF growth under 50% of QCOM's 3227.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
163.00%
10Y revenue/share CAGR under 50% of QCOM's 395.74%. Michael Burry would suspect a lasting competitive disadvantage.
25.66%
5Y revenue/share CAGR under 50% of QCOM's 112.56%. Michael Burry would suspect a significant competitive gap or product weakness.
17.83%
3Y revenue/share CAGR under 50% of QCOM's 45.37%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
66.82%
10Y OCF/share CAGR under 50% of QCOM's 1252.46%. Michael Burry would worry about a persistent underperformance in cash creation.
32.66%
Below 50% of QCOM's 100.08%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
38.83%
3Y OCF/share CAGR under 50% of QCOM's 82.52%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
628.47%
Net income/share CAGR 1.25-1.5x QCOM's 511.51%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-62.18%
Negative 5Y net income/share CAGR while QCOM is 69.48%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
30.50%
3Y net income/share CAGR 1.25-1.5x QCOM's 27.50%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
33.35%
Below 50% of QCOM's 334.28%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
14.54%
Below 50% of QCOM's 87.45%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
24.70%
Below 50% of QCOM's 57.71%. Michael Burry suspects a serious short-term disadvantage in building book value.
528.07%
Dividend/share CAGR of 528.07% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
328.75%
Dividend/share CAGR of 328.75% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.76%
3Y dividend/share CAGR of 29.76% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.63%
AR growth well above QCOM's 8.83%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.01%
Inventory growth well above QCOM's 5.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
28.46%
Asset growth above 1.5x QCOM's 8.09%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.09%
50-75% of QCOM's 7.90%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.47%
R&D dropping or stable vs. QCOM's 10.28%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.79%
SG&A declining or stable vs. QCOM's 33.87%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.